Cell therapy continues to be the leading therapeutic solution in the RegenerativPosted by rohan on November 23rd, 2017 According to the report Regenerative Medicine Market, published by Market Data Forecast, the Global market is projected to reach USD 60.3 billion by 2022, at a CAGR of 23.24% from 2017 to 2022. Regenerative Medicines are the medications that help in repair, replacement and regeneration of human cells. There are several factors affecting the damage cells like injury, diseases, aging or trauma. Some of these medicines like stem cells have the ability to proliferate and restore the original cell structure, tissue or organs. Regenerative Medicine Market: Drivers & Restraints Factors fuelling the growth of market are increasing demand for regenerative medicine derived from biological materials, rapid technological advancements like implementation of nanotechnology to make cell level repairs. Also, increasing funding for research and development for drug discovery and growing healthcare expenditure are also boosting the market. Yet, factors like ethical concerns regarding the utilization of human tissue and some post implantation complications are hindering the growth of market. Get accurate market forecast and analysis on the Regenerative Medicine Market. Request a sample to stay up-to-date on the main trends affecting this market: http://www.marketdataforecast.com/market-reports/global-regenerative-medicines-market-272/request-sample Regenerative Medicine Market: Segmentation By Product
By Therapy
By Application
By Geography
o United States o Canada
o U.K o Spain o Germany o Italy o France
o China o India o Japan o Australia o South Korea
o Brazil o Argentina o Mexico o Rest of Latin America
o Middle-East o Africa Regenerative Medicine Market: Overview Based on Type, cell-based products are occupying the maximum market share due to increasing awareness regarding the stem cell therapy and increasing funding for new stem cell lines. Based on therapy, the major share is attributed to cell based therapy due to increasing research activities and product innovations in the cell therapy segment and increasing focus towards research of stem cell therapy. Regionally, North America is dominating the market due to its established healthcare infrastructure and robust research facilities. However, Asia Pacific is expected to grow the fastest due to increasing funding for development of new technologies and increasing biobank establishments in the emerging economies like China, India and Japan. Regenerative Medicine Market: Key Players The key players in global regenerative medicines market such as, Vertex Pharmaceuticals Incorporated (U.S.), Acelity L.P. Inc. (U.S.), Celgene Corporation (U.S.), StemCells, Inc. (U.S.), Organogenesis Inc. (U.S.), NuVasive, Inc. (U.S.), Vericel Corporation (Genzyme) (U.S.), Japan Tissue Engineering Co., Ltd. (Japan), Cytori Therapeutics Inc. (U.S.), Advantagene, Inc. (U.S.), and Mesoblast Ltd. (Australia). About Market Data Forecast: Like it? Share it!More by this author |